WHO Medicines Strategy: Framework for Action in Essential Drugs and Medicines Policy 2000-2003. Geneva: WHO, 2000 (WHO/EDM/2000.1).
Progress in Essential Drugs and Medicines Policy 1998-1999. Geneva: WHO, 2000 (WHO/EDM/2000.2).
Global Comparative Pharmaceutical Expenditures with Related Reference Information. Health Economics and Drugs. EDM Series No. 3. Geneva: WHO, 2000, (EDM/PAR/2000.2).
Essential Drugs and Medicines Policy: A Selected Listing of Publications and Documents. Geneva: WHO, 2000 (WHO/EDM/2000.3).
Interagency Pharmaceutical Coordination Group: Report on Activities in 1996-1999 Geneva: WHO/UNICEF/UNFPA/World Bank, 2000.
International Nonproprietary Names (INN) for Pharmaceutical Substances. Cumulative List No. 9. Geneva: WHO, 1996. Quality Assurance of Pharmaceuticals: A Compendium of Guidelines and Related Materials. Vol. 1 & Vol. 2. Geneva: WHO, 1997, 1999.
Health Reform and Drug Financing: Selected Topics. Health Economics and Drugs. DAP Series No. 6. Geneva: WHO, 1998 (WHO/DAP/98.3).
Globalization and Access to Drugs: Perspectives on the WTO/TRIPS Agreement. Health Economics and Drugs. DAP Series No. 7. Geneva: WHO, 1998 (WHO/DAP/98.9-REV).
Counterfeit Drugs: Guidelines for the Development of Measures to Combat Counterfeit Drugs. Geneva: WHO, 1999 (WHO/EDM/QSA/99.1).
Effective Drug Regulation: What Can Countries Do? Geneva: WHO, 1999 (WHO/HTP/EDM/MAC(11)/99.6).
Guidelines for Drug Donations. Revised ed. Geneva: WHO, 1999 (WHO/EDM/PAR/99.4).
Strategy for Traditional Medicine. Geneva: WHO, 2001 (In preparation).
Regulatory Situation of Herbal Medicines: A Worldwide Review. Geneva: WHO, 1998 (WHO/TRM/98.1).
Management Sciences for Health/World Health Organization. Managing Drug Supply: The Selection, Procurement, Distribution, and Use of Pharmaceuticals, 2nd ed. West Hartford, CT: Kumarian Press, 1997.
See also: http://www.who.int/medicines/